DXCM DexCom, Inc. - Common Stock
$90,75
Preço · Ago 18, 2026
Fundamentais a partir de Jul 30, 2026
Intervalo 52 Semanas
$54–$92
97% of range
Classificação do Analista
BUY
36 analysts
Preço-Alvo
$93
+3% upside
P/E (TTM)
43.5
ROE
31.4%
Margem de Lucro Líquido
17.9%
Sobre DexCom, Inc. - Common Stock Visão geral da empresa da Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Ler mais
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
DXCM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$90.75
Capitalização de Mercado
$35.02B
P/E (TTM)
43.5
EPS (TTM)
$2.09
Receita (TTM)
$4.66B
Rendimento div.
—
ROE
31.4%
Dívida/Capital
—
Intervalo 52 Semanas
$54 – $92
DXCM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$4.66B
2016-12-31
→
2025-12-31
EPS
$2.09
2017-12-31
→
2025-12-31
Fluxo de caixa livre
$1.08B
2016-12-31
→
2025-12-31
Margens
17.9%
2018-12-31
→
2025-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DXCM
Mediana de Pares
P/E (TTM)
43.5
26.3
P/S (TTM)
7.5
4.4
P/B
12.8
5.3
Price / FCF (Preço / FCF)
32.5
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DXCM
Mediana de Pares
Gross Margin (Margem Bruta)
60.1%
63.1%
Operating Margin (Margem Operacional)
19.6%
—
Net Profit Margin (Margem de Lucro Líquido)
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DXCM
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
1.9
1.7
Quick Ratio (Índice de Liquidez Seca)
1.0
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DXCM
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
15.6%
—
Revenue CAGR 3Y (CAGR Receita 3A)
17.0%
—
Revenue CAGR 5Y (CAGR Receita 5A)
19.3%
—
EPS YoY
47.2%
—
Net Income YoY (Lucro Líquido Ano a Ano)
45.1%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DXCM
Mediana de Pares
DXCM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
36 analistas
- Compra forte 15 41,7%
- Compra 16 44,4%
- Manter 5 13,9%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
25 analistas · 2026-08-14
Mediana
$93.00
Agora
$90.75
Mín
$79.00
Máx
$115.00
Alvo mediano
$93.00
+2,5%
Alvo médio
$93.44
+3,0%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.05%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $0.70 | $0.62 | 0.08% |
| 31 de Março de 2026 | $0.56 | $0.48 | 0.08% |
| 31 de Dezembro de 2025 | $0.56 | $0.48 | 0.08% |
| 30 de Setembro de 2025 | $0.61 | $0.58 | 0.03% |
| 30 de Junho de 2025 | $0.48 | $0.45 | 0.03% |
| 31 de Março de 2025 | $0.32 | $0.33 | -0.01% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Fluxo de Caixa 19
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Taxas de Crescimento 9
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Demonstração de Resultados 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Fluxo de Caixa 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Margem Bruta % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Margem Operacional % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Lucro líquido | $836M | $576M | $542M | $341M | $217M |
| EPS Diluído | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Índice de Liquidez Seca | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.08B | $631M | $512M | $305M | $53M |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.087 declarantes · $16.0B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 131 (-28 vs trimestre anterior) | 96 (+4 vs trimestre anterior) | 386 (+17 vs trimestre anterior) | 352 (+6 vs trimestre anterior) | +42.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.697.876.797 | 25.209.752 | 10,61% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.323.867.969 | 19.656.540 | 8,27% | Ações |
| STATE STREET CORP | $1.237.947.284 | 18.380.806 | 7,73% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $751.533.926 | 11.199.611 | 4,70% | Ações |
| ALLIANCEBERNSTEIN L.P. | $734.346.085 | 11.693.409 | 4,59% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $545.031.559 | 8.092.525 | 3,41% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462.914.937 | 6.873.273 | 2,89% | Ações |
| NORGES BANK | $462.565.862 | 6.868.090 | 2,89% | Ações |
| Castle Hook Partners LP | $260.667.534 | 3.870.342 | 1,63% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231.614.091 | 3.438.962 | 1,45% | Ações |
| AMERICAN CENTURY COMPANIES INC | $206.860.340 | 3.071.423 | 1,29% | Ações |
| JANUS HENDERSON GROUP PLC | $162.720.013 | 2.591.083 | 1,02% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $152.790.681 | 2.268.607 | 0,95% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $149.327.006 | 2.217.179 | 0,93% | Ações |
| Employees Provident Fund Board | $147.498.453 | 2.190.029 | 0,92% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129.989.908 | 2.069.903 | 0,81% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $114.711.656 | 1.703.218 | 0,72% | Ações |
| BLAIR WILLIAM & CO/IL | $112.182.565 | 1.665.665 | 0,70% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $109.834.111 | 1.630.796 | 0,69% | Ações |
| RAYMOND JAMES FINANCIAL INC | $102.869.971 | 1.527.394 | 0,64% | Ações |
| BANK OF AMERICA CORP /DE/ | $97.103.277 | 1.441.771 | 0,61% | Ações |
| AMERIPRISE FINANCIAL INC | $93.336.259 | 1.385.802 | 0,58% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $92.130.221 | 1.367.932 | 0,58% | Ações |
| DSM CAPITAL PARTNERS LLC | $91.537.742 | 1.359.135 | 0,57% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89.939.931 | 1.335.411 | 0,56% | Ações |
| ROYAL BANK OF CANADA | $88.321.000 | 1.311.368 | 0,55% | Ações |
| GOLDMAN SACHS GROUP INC | $87.360.493 | 1.297.112 | 0,55% | Ações |
| CI INVESTMENTS INC. | $86.724.103 | 1.287.663 | 0,54% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85.826.193 | 1.274.331 | 0,54% | Ações |
| BANK OF NOVA SCOTIA | $85.283.937 | 1.266.285 | 0,53% | Ações |
| DNB Asset Management AS | $84.543.377 | 1.255.284 | 0,53% | Ações |
| Nearwater Capital Markets, Ltd | $84.187.500 | 1.250.000 | 0,53% | Ações |
| Stephens Investment Management Group LLC | $81.126.645 | 1.204.553 | 0,51% | Ações |
| Swedbank AB | $78.528.215 | 1.165.972 | 0,49% | Ações |
| BlackRock, Inc. | $77.389.460 | 1.149.064 | 0,48% | Ações |
| FMR LLC | $77.274.023 | 1.147.350 | 0,48% | Ações |
| CITADEL ADVISORS LLC | $75.864.589 | 1.126.423 | 0,47% | Ações |
| FIRST TRUST ADVISORS LP | $74.838.523 | 1.111.188 | 0,47% | Ações |
| HSBC HOLDINGS PLC | $73.861.872 | 1.080.800 | 0,46% | Opção de compra |
| Swiss National Bank | $73.108.425 | 1.085.500 | 0,46% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $71.040.241 | 1.054.792 | 0,44% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67.343.265 | 999.900 | 0,42% | Ações |
| CITADEL ADVISORS LLC | $64.656.000 | 960.000 | 0,40% | Opção de venda |
| Legal & General Group Plc | $64.638.083 | 959.734 | 0,40% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $64.478.600 | 957.366 | 0,40% | Ações |
| BAILLIE GIFFORD & CO | $63.928.755 | 949.202 | 0,40% | Ações |
| CIBC Bancorp USA Inc. | $62.958.645 | 932.286 | 0,39% | Ações |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61.865.555 | 918.568 | 0,39% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $59.044.465 | 876.681 | 0,37% | Ações |
| Chicago Capital, LLC | $58.393.062 | 867.009 | 0,36% | Ações |
| Fisher Funds Management LTD | $56.637.983 | 840.950 | 0,35% | Ações |
| Vanguard Global Advisers, LLC | $56.107.871 | 833.079 | 0,35% | Ações |
| JANE STREET GROUP, LLC | $56.062.140 | 832.400 | 0,35% | Opção de compra |
| Bellevue Group AG | $55.394.634 | 822.489 | 0,35% | Ações |
| Tri Locum Partners LP | $55.259.261 | 820.479 | 0,35% | Ações |
| RHUMBLINE ADVISERS | $51.735.803 | 768.165 | 0,32% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $51.168.667 | 759.743 | 0,32% | Ações |
| UBS Group AG | $51.066.858 | 758.231 | 0,32% | Ações |
| Allianz Asset Management GmbH | $50.820.963 | 809.251 | 0,32% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50.518.000 | 750.088 | 0,32% | Ações |
| BARCLAYS PLC | $50.351.331 | 747.607 | 0,31% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $49.968.851 | 741.928 | 0,31% | Ações |
| TWO SIGMA ADVISERS, LP | $49.649.804 | 748.076 | 0,31% | Ações |
| Smith Group Asset Management, LLC | $47.235.720 | 701.347 | 0,30% | Ações |
| NATIONAL BANK OF CANADA /FI/ | $46.761.576 | 694.307 | 0,29% | Ações |
| Assenagon Asset Management S.A. | $46.716.317 | 693.635 | 0,29% | Ações |
| NEUBERGER BERMAN GROUP LLC | $46.117.886 | 684.750 | 0,29% | Ações |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44.760.810 | 664.600 | 0,28% | Ações |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44.759.530 | 664.581 | 0,28% | Ações |
| Capital International Investors | $44.585.633 | 661.999 | 0,28% | Ações |
| CAPITAL FUND MANAGEMENT S.A. | $44.543.875 | 661.379 | 0,28% | Ações |
| Pictet Asset Management Holding SA | $44.534.379 | 661.238 | 0,28% | Ações |
| National Pension Service | $44.471.811 | 660.309 | 0,28% | Ações |
| California Public Employees Retirement System | $42.988.899 | 638.291 | 0,27% | Ações |
| Korea Investment CORP | $42.608.237 | 632.639 | 0,27% | Ações |
| ING GROEP NV | $41.334.513 | 613.727 | 0,26% | Ações |
| Susquehanna Portfolio Strategies, LLC | $41.226.753 | 612.127 | 0,26% | Ações |
| MIG Capital, LLC | $40.190.154 | 605.547 | 0,25% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39.472.718 | 584.004 | 0,25% | Ações |
| Quantinno Capital Management LP | $39.303.248 | 583.567 | 0,25% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36.898.831 | 587.561 | 0,23% | Ações |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36.855.267 | 547.220 | 0,23% | Ações |
| FACTORY MUTUAL INSURANCE CO | $36.222.851 | 537.830 | 0,23% | Ações |
| Woodline Partners LP | $36.146.880 | 536.702 | 0,23% | Ações |
| Parkman Healthcare Partners LLC | $36.016.557 | 534.767 | 0,23% | Ações |
| MARSHALL WACE, LLP | $35.884.349 | 532.804 | 0,22% | Ações |
| Walleye Trading LLC | $35.823.465 | 531.900 | 0,22% | Opção de compra |
| EVENTIDE ASSET MANAGEMENT, LLC | $33.574.377 | 498.202 | 0,21% | Ações |
| Blue Sparrow, LLC /DE | $32.368.410 | 480.600 | 0,20% | Ações |
| Trexquant Investment LP | $31.938.380 | 474.215 | 0,20% | Ações |
| Cubist Systematic Strategies, LLC | $31.905.647 | 474.151 | 0,20% | Ações |
| UBS Group AG | $31.896.960 | 473.600 | 0,20% | Opção de venda |
| Mitsubishi UFJ Trust & Banking Corp | $31.227.164 | 463.655 | 0,20% | Ações |
| USS Investment Management Ltd | $30.910.132 | 459.050 | 0,19% | Ações |
| OFI INVEST ASSET MANAGEMENT | $29.454.211 | 500.000 | 0,18% | Ações |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29.397.534 | 436.489 | 0,18% | Ações |
| ProShare Advisors LLC | $28.566.636 | 424.152 | 0,18% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28.528.135 | 427.840 | 0,18% | Ações |
| SIRIOS CAPITAL MANAGEMENT L P | $28.315.152 | 420.418 | 0,18% | Ações |
| Bridgewater Associates, LP | $27.002.568 | 400.929 | 0,17% | Ações |
Executivos da empresa 60 insiders · 36 diretores · 23 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 de Maio de 2026 F | 420.359 | 2 | 0 | $1.001.761 |
| Andrew P Rasdal | President & CEO | 2 de Maio de 2006 M | 2.944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 de Março de 2017 S | 8.452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 de Maio de 2007 A | 26.255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 de Setembro de 2021 S | 19.280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | 20 de Julho de 2026 S | 328.970 | 0 | 3 | $-5.895.098 |
| Jon Coleman | EVP, Chief Commercial Officer | 4 de Junho de 2026 S | 95.450 | 0 | 2 | $-722.628 |
| Sadie Stern | EVP Chief People & Culture Off | 22 de Maio de 2026 F | 130.059 | 0 | 1 | $-117.280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 22 de Maio de 2026 F | 151.841 | 0 | 1 | $-357.796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 de Janeiro de 2025 S | 42.044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 de Março de 2024 S | 66.641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 de Dezembro de 2023 D | 48.949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 de Dezembro de 2023 D | 58.469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 de Novembro de 2023 S | 124.775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9 de Novembro de 2023 S | 47.725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 de Setembro de 2023 D | 48.453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 de Março de 2023 D | 208.023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 de Março de 2023 D | 50.908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9 de Maio de 2022 S | 13.675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9 de Março de 2022 D | 13.789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9 de Setembro de 2021 S | 16.254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 de Março de 2021 S | 6.654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9 de Setembro de 2020 D | 34.784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 de Março de 2020 S | 38.584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 de Julho de 2018 S | 50.882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9 de Março de 2017 M | 84.034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 de Novembro de 2010 P | 3.387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 de Agosto de 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 de Março de 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 de Março de 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 de Março de 2010 A | 18.741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 de Maio de 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 de Março de 2008 A | 53.125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2 de Novembro de 2007 A | 10.967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2 de Agosto de 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9 de Março de 2007 A | — | 0 | 0 | $0 |
| Mark G Foletta | Conselheiro | 3 de Agosto de 2026 S | 48.852 | 0 | 4 | $-627.183 |
| Albert Frederick Osterloh IV | Conselheiro | 28 de Maio de 2026 A | 8.691 | 0 | 0 | $0 |
| Euan A. Ashley | Conselheiro | 28 de Maio de 2026 A | 12.731 | 0 | 0 | $0 |
| Rimma Driscoll | Conselheiro | 28 de Maio de 2026 A | 17.319 | 0 | 0 | $0 |
| Kyle Malady | Conselheiro | 28 de Maio de 2026 A | 28.242 | 0 | 1 | $-53.934 |
| Richard Alexander Collins | Conselheiro | 28 de Maio de 2026 A | 5.605 | 0 | 2 | $-389.410 |
| Renee D Gala | Conselheiro | 28 de Maio de 2026 A | 12.486 | 0 | 0 | $0 |
| Steven R Altman | Conselheiro | 28 de Maio de 2026 A | 5.565 | 0 | 0 | $0 |
| Karen M Dahut | Conselheiro | 8 de Maio de 2025 G | 17.779 | 0 | 0 | $0 |
| Eric Topol | Conselheiro | 8 de Maio de 2025 G | 380.545 | 0 | 0 | $0 |
| Barbara Kahn | Conselheiro | 18 de Maio de 2024 G | 22.575 | 0 | 0 | $0 |
| Jay S Skyler | Conselheiro | 18 de Maio de 2023 G | 63.348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Conselheiro | 1 de Setembro de 2016 S | 52.820 | 0 | 0 | $0 |
| Martin Doordan | Conselheiro | 1 de Junho de 2012 A | 39.633 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 197 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| TMFM · RBB Fund, Inc. | 5,18% | 81.981 NS | 31 de Maio de 2026 | N-PORT |
| HEAL · Global X Funds | 4,89% | 16.599 NS | 31 de Maio de 2026 | N-PORT |
| SNSR · Global X Funds | 4,74% | 161.491 NS | 31 de Maio de 2026 | N-PORT |
| IHI · iShares Trust | 4,54% | 1.828.483 SH | 8 de Agosto de 2026 | Diário |
| GDOC · Goldman Sachs ETF Trust | 2,79% | 7.621 NS | 31 de Maio de 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2,33% | 112.503 NS | 31 de Maio de 2026 | N-PORT |
| AGNG · Global X Funds | 2,01% | 22.316 NS | 31 de Maio de 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,92% | 13.512 NS | 31 de Maio de 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,91% | 5.848 NS | 30 de Abril de 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 952 NS | 30 de Abril de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 158.549 SH | 8 de Agosto de 2026 | Diário |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,42% | 389.654 SH | 8 de Agosto de 2026 | Diário |
| TMFX · RBB Fund, Inc. | 1,37% | 5.955 NS | 31 de Maio de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6.533 NS | 31 de Maio de 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,17% | 15.853 NS | 31 de Maio de 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1,01% | 10.206 NS | 31 de Maio de 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1,01% | 302.231 NS | 31 de Maio de 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1,00% | 18.376 NS | 31 de Maio de 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,99% | 1.867 NS | 30 de Abril de 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,97% | 17.329 NS | 30 de Abril de 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,92% | 6.459 NS | 30 de Abril de 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 0,91% | 4.208 NS | 31 de Maio de 2026 | N-PORT |
| IWP · iShares Trust | 0,91% | 2.217.346 SH | 8 de Agosto de 2026 | Diário |
| SDG · iShares Trust | 0,87% | 18.232 SH | 8 de Agosto de 2026 | Diário |
| MEDI · Harbor ETF Trust | 0,84% | 3.888 NS | 30 de Abril de 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,80% | 163.528 NS | 30 de Abril de 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,76% | 296.418 NS | 31 de Maio de 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,67% | 56.679 NS | 31 de Maio de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,64% | 1.196 NS | 30 de Abril de 2026 | N-PORT |
| QNXT · iShares Trust | 0,59% | 2.014 SH | 8 de Agosto de 2026 | Diário |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2.956.203 SH | 8 de Agosto de 2026 | Diário |
| IYH · iShares Trust | 0,52% | 229.458 SH | 8 de Agosto de 2026 | Diário |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,46% | 1.074.035 SH | 8 de Agosto de 2026 | Diário |
| IMCG · iShares Trust | 0,43% | 209.424 SH | 8 de Agosto de 2026 | Diário |
| RXL · ProShares Trust | 0,41% | 4.013 NS | 31 de Maio de 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,41% | 2.617 NS | 30 de Abril de 2026 | N-PORT |
| IXJ · iShares Trust | 0,40% | 202.443 SH | 8 de Agosto de 2026 | Diário |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 56.496 NS | 30 de Abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,38% | 1.156.710 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,38% | 179.798 NS | 30 de Abril de 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23.742 SH | 8 de Agosto de 2026 | Diário |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,33% | 4.233 NS | 31 de Maio de 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,33% | 18.233 NS | 31 de Maio de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,33% | 7.675 NS | 30 de Abril de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,32% | 11.239 NS | 31 de Maio de 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,32% | 9.251 NS | 31 de Maio de 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,32% | 558.304 NS | 31 de Maio de 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0,32% | 3.671 NS | 31 de Maio de 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,30% | 64.292 NS | 30 de Abril de 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 7.662 NS | 31 de Maio de 2026 | N-PORT |